Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artificial saliva vs artificial saliva + ilaprazole for burning mouth syndrome due to laryngopharyngeal reflux
KCT0004329Phase 4Not yet recruiting
- Sponsor
- Il-Yang Pharmaceutical
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ilaprazole in glossodynia (BMS), laryngopharyngeal reflux (LPR), sponsored by Il-Yang Pharmaceutical. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
ilaprazole
03
Conditions
glossodynia (BMS)laryngopharyngeal reflux (LPR)
Beyond the preview
Go deeper on KCT0004329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004329.